Shouyao Holdings (Beijing) Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 82.25%

Shouyao Holdings (Beijing) Co. Ltd. A (688197) has an Asset Resilience Ratio of 82.25% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥635.46 Million
≈ $92.99 Million USD Cash + Short-term Investments

Total Assets

CN¥772.57 Million
≈ $113.05 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shouyao Holdings (Beijing) Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688197 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Shouyao Holdings (Beijing) Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shouyao Holdings (Beijing) Co. Ltd. A stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥635.46 Million 82.25%
Total Liquid Assets CN¥635.46 Million 82.25%

Asset Resilience Insights

  • Very High Liquidity: Shouyao Holdings (Beijing) Co. Ltd. A maintains exceptional liquid asset reserves at 82.25% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Shouyao Holdings (Beijing) Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shouyao Holdings (Beijing) Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Prostemics Co. Ltd
KQ:203690
Biotechnology 0.31%
ORUM
KQ:475830
Biotechnology 82.74%
TELIX Pharmaceuticals Ltd
AU:TLX
Biotechnology 32.29%
TG Therapeutics Inc
NASDAQ:TGTX
Biotechnology 4.72%
Green Cross Holdings Preference Shares
KO:005257
Biotechnology 0.50%
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Biotechnology 33.70%
NEWRON PHARMACEUT. EO-20
XETRA:NP5
Biotechnology 41.67%
Cybin Inc
NEO:CYBN
Biotechnology 0.21%

Annual Asset Resilience Ratio for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shouyao Holdings (Beijing) Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 82.69% CN¥654.26 Million
≈ $95.74 Million
CN¥791.23 Million
≈ $115.78 Million
+2.73pp
2024-12-31 79.96% CN¥737.41 Million
≈ $107.91 Million
CN¥922.23 Million
≈ $134.95 Million
+70.95pp
2023-12-31 9.00% CN¥100.14 Million
≈ $14.65 Million
CN¥1.11 Billion
≈ $162.74 Million
-13.94pp
2019-12-31 22.94% CN¥50.21 Million
≈ $7.35 Million
CN¥218.89 Million
≈ $32.03 Million
--
pp = percentage points

About Shouyao Holdings (Beijing) Co. Ltd. A

SHG:688197 China Biotechnology
Market Cap
$710.32 Million
CN¥4.85 Billion CNY
Market Cap Rank
#10462 Global
#2800 in China
Share Price
CN¥32.64
Change (1 day)
-1.33%
52-Week Range
CN¥30.37 - CN¥55.94
All Time High
CN¥66.15
About

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, … Read more